Csl Ltd ADR (CSLLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSLLY | ARGX | ALNY | ||
| Company | Csl Ltd ADR | Argenx Se ADR | Alnylam Pharmaceuticals | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 21.7285 | 787.08 | 295.91 | ||
| High | 21.7900 | 792.00 | 300.17 | ||
| Low | 21.6400 | 778.13 | 293.06 | ||
| Latest | 21.7100 | 782.17 | 295.05 | ||
| Change | -0.1000 | -5.14 | -0.86 | ||
| % Change | -0.46% | -0.65% | -0.29% | ||
| Volume | 296,500 | 354,300 | 926,700 | ||
| 20-Day Average Volume | 450,015 | 309,705 | 1,144,490 | ||
| Previous Close | 21.8100 | 787.31 | 295.91 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 23.3358 | 802.00 | 309.76 | ||
| 20-Day Raw Stochastic | 2.36% | 28.04% | 14.28% | ||
| 20-Day Relative Strength | 34.99 | 50.01 | 40.82 | ||
| Weighted Alpha | -47.17 | +31.37 | -5.15 | ||
| Today's Opinion | 100% Sell | 8% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 8% Buy | 100% Sell | ||
| Last Month's Opinion | 88% Sell | 8% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.08% since 05/01/26 | -0.17% since 05/01/26 | -0.36% since 05/01/26 | ||
| Low | 21.6400 on 05/08/26 | 777.14 on 05/07/26 | 288.05 on 05/04/26 | ||
| High | 22.8100 on 05/06/26 | 840.67 on 05/07/26 | 306.03 on 05/06/26 | ||
| 1-Month | |||||
| %Chg | -13.61% since 04/08/26 | -0.37% since 04/08/26 | -9.84% since 04/08/26 | ||
| Low | 21.6100 on 04/29/26 | 754.84 on 04/29/26 | 287.00 on 04/30/26 | ||
| High | 25.8400 on 04/15/26 | 852.28 on 04/17/26 | 343.36 on 04/14/26 | ||
| 3-Month | |||||
| %Chg | -32.39% since 02/06/26 | -3.61% since 02/06/26 | -10.09% since 02/06/26 | ||
| Low | 21.6100 on 04/29/26 | 661.85 on 03/20/26 | 287.00 on 04/30/26 | ||
| High | 33.5316 on 02/10/26 | 852.83 on 02/17/26 | 345.89 on 02/20/26 | ||
| 6-Month | |||||
| %Chg | -25.27% since 11/07/25 | -8.48% since 11/07/25 | -33.35% since 11/07/25 | ||
| Low | 21.6100 on 04/29/26 | 661.85 on 03/20/26 | 287.00 on 04/30/26 | ||
| High | 33.5316 on 02/10/26 | 934.62 on 12/03/25 | 479.79 on 12/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 42,145,100 | 48,641,580 | 39,393,008 | ||
| Shares Outstanding, K | 1,941,276 | 62,188 | 133,513 | ||
| Annual Sales | 15,558,000,000 | 4,248,050,000 | 3,713,940,000 | ||
| Annual Net Income | 3,002,000,000 | 1,292,040,000 | 313,750,000 | ||
| Last Quarter Sales | N/A | 1,322,160,000 | 1,167,180,000 | ||
| Last Quarter Net Income | N/A | 532,950,000 | 205,990,000 | ||
| 60-Month Beta | 0.69 | 0.46 | 0.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 8.02 on 02/26/26 | 1.99 on 04/30/26 | ||
| Earnings Date | 08/19/25 | 07/30/26 | 07/30/26 | ||
| Most Recent Dividend | 0.294 on 03/11/26 | N/A | N/A | ||
| Next Ex-Dividends Date | 03/11/26 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 35.05 | 81.07 | ||